Cantor Fitzgerald Reaffirms Their Buy Rating on Phathom Pharmaceuticals (PHAT)
at www.tipranks.com (Wed, 14-Jan 8:28 AM)
Phathom Pharmaceuticals Secures $130 Million Through Public Offering—What This Means for Future Growth
Market Chameleon (Thu, 8-Jan 8:37 AM)
Phathom Pharmaceuticals Lifts Full-Year Guidance as VOQUEZNA Scripts and Profitability Prospects Accelerate
Market Chameleon (Thu, 30-Oct 8:38 AM)
